
USFDA APPLICATION NUMBER - 21016 / DOSAGE - TABLET;ORAL - EQ 40MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| ELETRIPTAN HYDROBROMIDE(UNII: M41W832TA3) (ELETRIPTAN - UNII:22QOO9B8KI) | ELETRIPTAN | 40mg |
Inactive Ingredients
| Ingredient Name | U.S. Pharmaceuticals | Zydus Pharmaceuticals USA Inc. | Teva Pharmaceuticals USA, Inc. |
|---|---|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |||
| ANHYDROUS LACTOSE(3SY5LH9PMK) | |||
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |||
| D&C YELLOW NO. 10(35SW5USQ3G) | |||
| FD&C BLUE NO. 2--ALUMINUM LAKE(4AQJ3LG584) | |||
| FD&C YELLOW NO. 6(H77VEI93A8) | |||
| FERRIC OXIDE RED(1K09F3G675) | |||
| FERRIC OXIDE YELLOW(EX438O2MRT) | |||
| HYPROMELLOSE 2910 (3 MPA.S)(0VUT3PMY82) | |||
| HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6) | |||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |||
| HYPROMELLOSES(3NXW29V3WO) | |||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |||
| LACTOSE, UNSPECIFIED FORM(J2B2A4N98G) | |||
| MAGNESIUM STEARATE(70097M6I30) | |||
| MICROCRYSTALLINE CELLULOSE 112(X7XJ6RM9Q2) | |||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||
| POLYDEXTROSE(VH2XOU12IE) | |||
| POLYETHYLENE GLYCOL 8000(Q662QK8M3B) | |||
| POVIDONE K30(U725QWY32X) | |||
| SILICON DIOXIDE(ETJ7Z6XBU4) | |||
| TITANIUM DIOXIDE(15FIX9V2JP) | |||
| TRIACETIN(XHX3C3X673) |